Bristol-Myers Squibb Pharma EEIG:

Please note that on November‌ 2, 2026, CDI sent the Notification of Drug Inspection Results of Mezigdomide Capsules to the agency of the medicine in China.

If there are any questions, please do not hesitate to contact us as soon as possible.

Contact: Liu Jinxin

Tel. +86 10 68441674

Center for Drug Inspection of NMPA
November‌ 2, 2026